Re: Final Report of the Intergroup Randomized Study of Combined Androgen-Deprivation Therapy Plus Radiotherapy Versus Androgen-Deprivation Therapy Alone in Locally Advanced Prostate Cancer

被引:0
|
作者
Ozkan, Tayyar Alp
机构
来源
JOURNAL OF UROLOGICAL SURGERY | 2015年 / 2卷 / 02期
关键词
D O I
10.4274/jus.2015.02.007
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:107 / 107
页数:1
相关论文
共 50 条
  • [31] Reimbursement Policy and Androgen-Deprivation Therapy for Prostate Cancer REPLY
    Shahinian, Vahakn B.
    Kuo, Yong-Fang
    Gilbert, Scott M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (06): : 580 - 580
  • [32] Age and androgen-deprivation therapy on exercise outcomes in men with prostate cancer
    Alberga, Angela S.
    Segal, Roanne J.
    Reid, Robert D.
    Scott, Chris G.
    Sigal, Ronald J.
    Khandwala, Farah
    Jaffey, James
    Wells, George A.
    Kenny, Glen P.
    SUPPORTIVE CARE IN CANCER, 2012, 20 (05) : 971 - 981
  • [33] Harms of Intermittent vs Continuous Androgen-Deprivation Therapy for Prostate Cancer
    Niraula, Saroj
    Tannock, Ian F.
    JAMA ONCOLOGY, 2016, 2 (04) : 461 - 462
  • [34] Androgen-deprivation therapy alone versus combined with radiation therapy or chemotherapy for nonlocalized prostate cancer: a systematic review and meta-analysis
    Lei, Jun-Hao
    Liu, Liang-Ren
    Wei, Qiang
    Song, Tu-Run
    Yang, Lu
    Meng, Yang
    Han, Ping
    ASIAN JOURNAL OF ANDROLOGY, 2016, 18 (01) : 102 - 107
  • [35] UROLOGICAL CANCER The benefits of intermittent androgen-deprivation therapy
    Mitin, Timur
    Efstathiou, Jason A.
    Shipley, William U.
    NATURE REVIEWS CLINICAL ONCOLOGY, 2012, 9 (12) : 672 - 673
  • [36] Androgen-Deprivation Therapy Is More Than Palliation in Oligometastatic Prostate Cancer
    Cattrini, Carlo
    Zanardi, Elisa
    Boccardo, Francesco
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (22) : 2350 - +
  • [37] Androgen-deprivation therapy in prostate cancer: clinical evidence and future perspectives
    Pinto, F.
    Calarco, A.
    Totaro, A.
    Sacco, E.
    Volpe, A.
    Racioppi, M.
    D'Addessi, A.
    Bassi, P. F.
    UROLOGIA JOURNAL, 2010, 77 (02) : 71 - 83
  • [38] Immediate versus deferred androgen-deprivation therapy for prostate cancer: the jury is still out
    Zlotta, Alexandre R.
    Schulman, Claude
    NATURE CLINICAL PRACTICE UROLOGY, 2006, 3 (09): : 474 - 475
  • [39] Degarelix/bicalutamide combination versus degarelix alone as initial androgen-deprivation therapy
    Nozawa, Masahiro
    Sugimoto, Koichi
    Nagai, Yasuharu
    Sugiyama, Takahide
    Hatanaka, Yuji
    Oki, Takashi
    Tahara, Hideo
    Matsuda, Hisao
    Yamamoto, Yutaka
    Uemura, Hirotsugu
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [40] Age and androgen-deprivation therapy on exercise outcomes in men with prostate cancer
    Angela S. Alberga
    Roanne J. Segal
    Robert D. Reid
    Chris G. Scott
    Ronald J. Sigal
    Farah Khandwala
    James Jaffey
    George A. Wells
    Glen P. Kenny
    Supportive Care in Cancer, 2012, 20 : 971 - 981